LACTOSE (INDIA)
|
LACTOSE (INDIA) Last 5 Year Financial Ratios History
[Standalone]
| Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.96 | 1.95 | -2.17 | 0.07 | 0.71 |
| CEPS(Rs) | 4.68 | 5.57 | 1.64 | 3.90 | 4.24 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 32.22 | 31.21 | 30.15 | 33.65 | 33.61 |
| Tax Rate(%) | 17.47 | 22.58 | 24.24 | 27.49 | 32.97 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 17.41 | 26.69 | 17.80 | 23.14 | 23.66 |
| EBIT Margin(%) | 11.40 | 18.03 | 6.23 | 14.12 | 15.83 |
| Pre Tax Margin(%) | 2.23 | 6.89 | -9.35 | 0.25 | 2.65 |
| PAT Margin (%) | 1.84 | 5.34 | -7.09 | 0.18 | 1.77 |
| Cash Profit Margin (%) | 8.96 | 15.26 | 5.38 | 9.93 | 10.65 |
| Performance Ratios | |||||
| ROA(%) | 1.26 | 2.75 | -2.88 | 0.09 | 0.88 |
| ROE(%) | 3.03 | 6.65 | -7.21 | 0.21 | 2.20 |
| ROCE(%) | 9.35 | 10.21 | 2.81 | 7.84 | 9.13 |
| Asset Turnover(x) | 0.69 | 0.51 | 0.41 | 0.48 | 0.49 |
| Sales/Fixed Asset(x) | 0.81 | 0.58 | 0.46 | 0.55 | 0.58 |
| Working Capital/Sales(x) | 6.02 | 5.86 | 4.33 | 4.77 | 7.27 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.24 | 1.73 | 2.20 | 1.83 | 1.72 |
| Receivable days | 66.13 | 70.62 | 70.00 | 63.14 | 55.08 |
| Inventory Days | 82.93 | 61.34 | 89.94 | 77.56 | 68.50 |
| Payable days | 167.54 | 165.11 | 253.97 | 288.89 | 305.66 |
| Valuation Parameters | |||||
| PER(x) | 45.81 | 30.79 | - | 237.62 | 48.38 |
| PCE(x) | 9.39 | 10.77 | 16.24 | 4.30 | 8.06 |
| Price/Book(x) | 1.37 | 1.92 | 0.89 | 0.50 | 1.02 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.42 | 2.51 | 2.12 | 1.36 | 1.74 |
| EV/Core EBITDA(x) | 7.65 | 8.97 | 11.33 | 5.69 | 7.03 |
| EV/EBIT(x) | 12.44 | 13.91 | 33.99 | 9.62 | 10.97 |
| EV/CE(x) | 0.92 | 1.28 | 0.84 | 0.65 | 0.86 |
| M Cap / Sales | 0.84 | 1.64 | 0.87 | 0.43 | 0.86 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 43.23 | 31.39 | -12.70 | -1.38 | 30.56 |
| Core EBITDA Growth(%) | -5.11 | 96.48 | -31.65 | -4.68 | 59.78 |
| EBIT Growth(%) | -9.44 | 280.34 | -61.50 | -12.00 | 139.19 |
| PAT Growth(%) | -50.69 | 198.94 | -3,540.97 | -90.00 | 154.18 |
| EPS Growth(%) | -50.69 | 189.89 | -3,163.95 | -90.00 | 153.38 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.96 | 1.06 | 1.34 | 1.14 | 1.07 |
| Current Ratio(x) | 1.41 | 1.53 | 1.69 | 1.74 | 1.46 |
| Quick Ratio(x) | 0.55 | 1.05 | 0.98 | 0.96 | 0.79 |
| Interest Cover(x) | 1.24 | 1.62 | 0.40 | 1.02 | 1.20 |
| Total Debt/Mcap(x) | 0.70 | 0.55 | 1.51 | 2.29 | 1.05 |
Compare Financial Ratios of peers of LACTOSE (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LACTOSE (INDIA) | ₹171.0 Cr | 4.9% | -6.9% | 192.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹368,598.0 Cr | 2.3% | -0.8% | 60.8% | Stock Analytics | |
| CIPLA | ₹114,654.0 Cr | 3.5% | 0.7% | 43.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹104,348.0 Cr | 2.7% | 3% | 17.1% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹101,499.0 Cr | 3.1% | 3.8% | 91.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,429.4 Cr | -0.1% | -3.5% | 29.5% | Stock Analytics | |
LACTOSE (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LACTOSE (INDIA) | 4.9% |
-6.9% |
192.2% |
| SENSEX | 1.7% |
-0.8% |
19% |
You may also like the below Video Courses
